Siemens Healthineers AG (OTCMKTS:SMMNY) Short Interest Up 72.4% in April

Siemens Healthineers AG (OTCMKTS:SMMNY – Get Rating) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 42,400 shares, an increase of 72.4% from the April 15th total of 24,600 shares. Based on an average daily trading volume, of 139,700 shares, the short-interest ratio is presently 0.3 days.

A number of research firms recently commented on SMMNY. Societe Generale upgraded shares of Siemens Healthineers from a “hold” rating to a “buy” rating in a research note on Wednesday, January 19th. Kepler Capital Markets upgraded shares of Siemens Healthineers from a “hold” rating to a “buy” rating in a research note on Monday, March 14th. Jefferies Financial Group upgraded shares of Siemens Healthineers from a “hold” rating to a “buy” rating in a research report on Thursday, January 20th. The Goldman Sachs Group began coverage on shares of Siemens Healthineers in a research report on Thursday, January 20th. They issued a “buy” rating on the stock. Finally, JPMorgan Chase & Co. decreased their price target on shares of Siemens Healthineers from €77.50 ($81.58) to €71.10 ($74.84) and set an “overweight” rating on the stock in a research report on Friday, February 4th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, Siemens Healthineers currently has a consensus rating of “Buy” and a consensus target price of $71.05.

Shares of SMMNY opened at $28.21 on Friday. Siemens Healthineers has a one year low of $26.13 and a one year high of $38.23. The company’s fifty day moving average price is $29.41 and its 200 day moving average price is $32.69.

Siemens Healthineers Company Profile (Get Rating)

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.

Featured Stories